Trilogy Capital’s Walmart Inc WMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$833K Sell
7,351
-42
-0.6% -$5.21K 0.03% 219
2026
Q1
$919K Sell
7,393
-86
-1% -$10.6K 0.04% 201
2025
Q4
$833K Sell
7,479
-67
-0.9% -$7.19K 0.04% 202
2025
Q3
$778K Buy
7,546
+72
+1% +$7.17K 0.04% 200
2025
Q2
$731K Buy
7,474
+34
+0.5% +$3.24K 0.04% 198
2025
Q1
$653K Sell
7,440
-449
-6% -$42.1K 0.03% 198
2024
Q4
$713K Sell
7,889
-955
-11% -$82.9K 0.04% 198
2024
Q3
$714K Sell
8,844
-142
-2% -$10.4K 0.04% 196
2024
Q2
$608K Sell
8,986
-109
-1% -$6.86K 0.03% 205
2024
Q1
$547K Buy
9,095
+4,661
+105% +$267K 0.03% 191
2023
Q4
$233K Hold
4,434
0.01% 242
2023
Q3
$236K Sell
4,434
-1,050
-19% -$55.9K 0.02% 237
2023
Q2
$290K Buy
+5,484
New +$277K 0.02% 237
2018
Q4
Sell
-1,230
Closed -$39K 575
2018
Q3
$39K Buy
1,230
+120
+11% +$3.67K ﹤0.01% 218
2018
Q2
$32K Buy
1,110
+312
+39% +$8.87K ﹤0.01% 216
2018
Q1
$24K Sell
798
-20,079
-96% -$646K ﹤0.01% 211
2017
Q4
$687K Buy
+20,877
New +$639K 0.11% 56

Other funds holding WMT

Trilogy Capital's WMT Position: Q2 2026 in Review

Trilogy Capital reduced its Walmart Inc (WMT) stake by 0.57% in Q2 2026, selling an estimated $5.21K and leaving 7,351 shares worth $833K. The position accounts for 0.03% of the portfolio, ranked #219.

Trilogy Capital first reported a position in WMT in Q4 2017 and has held it in 17 quarters since. The position peaked at $919K in Q1 2026. 2,199 funds tracked by Wall St. Rank hold WMT as of Q2 2026.

  • Trilogy Capital held 7,351 shares of Walmart Inc worth $833K as of Q2 2026.
  • Trilogy Capital sold 42 Walmart Inc shares in Q2 2026, an estimated $5.21K.
  • Walmart Inc made up 0.03% of Trilogy Capital's portfolio in Q2 2026, its #219 holding.
  • Trilogy Capital first reported a position in Walmart Inc in Q4 2017 and has held it in 17 quarters since.
  • Trilogy Capital's Walmart Inc position peaked at $919K in Q1 2026.
  • 2,199 funds tracked by Wall St. Rank held Walmart Inc as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.